Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21)

The purpose of this grant is to support research which can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses.  Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation.  

Funding: $275,000 total 

Duration: 2 years

Research Autority due date: 10 days prior to submission 

LOI (encouraged) due date: 10.5.19, 6.10.19, 20.5.20, 6.10.20, 10.5.21, 8.10.21

Full proposal due date: 10.6.19, 6.11.19, 20.6.20, 6.11.20, 10.6.21, 8.11.21